Edoxaban


( Last Updated : June 8, 2016)
Generic Name:
Edoxaban
Project Status:
Complete
Therapeutic Area:
Nonvalvular atrial fibrillation, prevention of stroke and systemic embolism.
Manufacturer:
Daiichi Sankyo, Inc.
Call for patient/clinician input open:
Brand Name:
Lixiana NVAF
Project Line:
Reimbursement Review
Project Number:
SR0500-000
Call for patient/clinician input closed:

Details


Submission Type:
Initial
Indications:
Nonvalvular atrial fibrillation, prevention of stroke and systemic embolism
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation: